Given the uncertainties of the pathogenesis of lupus nephritis, the need to correlate specific histologic findings with treatment and outcomes, and the need to identify biomarkers that accurately ...
Conventional lupus nephritis (LN) treatment based on cyclophosphamide, steroids and, recently, mycophenolatemofetil has improved the outcome of the disease over the last 50 years, although failure ...
Our research is improving the day-to-day lives of people with lupus now, easing their suffering while providing hope as we work toward earlier diagnosis, improved care, and better treatments. We are ...
THE RESULTS ARE PROMISING. IN 2021, THE FIRST LUPUS PATIENT RECEIVED THE TREATMENT IN GERMANY. DOCTOR CARRICO SAYS IT’S A GAME CHANGER. WITHOUT THIS TREATMENT, WE WOULDN’T KNOW WHAT TO DO.
This Phase II study of mesenchymal stem cells is an early step in determining whether stem cell treatments hold promise as a safe, effective alternative for people with lupus who do not benefit from ...
Lupus nephritis (LN) is one of the most serious ... Results from these studies bring new insights for real effective treatment in LN and thus achieve a better outcome in patients.
It can manifest as mild gastrointestinal discomfort or as part of more severe conditions like lupus peritonitis. Effective management may include a combination of medical treatments, like anti ...